catalog number :
MBS855774
products full name :
ACER1
products short name :
[ACER1]
other names :
[alkaline ceramidase 1; Alkaline ceramidase 1; alkaline ceramidase 1; alkaline ceramidase 1; Acylsphingosine deacylase 3; N-acylsphingosine amidohydrolase 3]
products gene name :
[ACER1]
other gene names :
[ACER1; ACER1; ASAH3; ALKCDase1; ASAH3; AlkCDase 1; Alkaline CDase 1]
reactivity :
Human. Not yet tested in other species.
form :
Lyophilized anti -ACER1antibody purified by peptide affinity column containing 0.5% BSA and 0.02% NaN 3 .
storage stability :
Already reconstituted in 200ul sterile H2O. The antibody is stable for at least one year when stored at-20°C after reconstitution. Avoid repeated freeze/defrost cycles.
tested application :
Peptide ELISA titer: 1:5,000-1:10,000 . Western blot analysis: 1:500-1:1,000. Immunohistochemistry: 1:100-500 . Optimal dilutions/concentrations should be determined by the end user.
app notes :
Peptide ELISA: 1:5,000-1:10,000. WB: 1:500-1:1,000. IHC: 1:100-500
image1 heading :
Testing Data
image2 heading :
Testing Data
other info1 :
Host Note: Rabbit polyclonal ACER1 (1) antibody was raised against a peptide from C terminal residues of human ACER1 protein.
products categories :
Autophagy antibody; Cancer; Cardiovascular; Cell Biology; Epigenetics & Nuclear Signaling; Developmental Biologys; Immunology; Drug Discovery Products; Metabolism; Neuroscience; Signal Transduction; Stem Cells
products description :
Rabbit polyclonal ACER1 (1) antibody was raised against a peptide from C terminal residues of human ACER1 protein.
products references :
(1) Sun, W., Xu, R., Hu, W., et al. Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J. Invest. Dermatol. 128 (2), 389-397 (2008).
ncbi acc num :
NP_597999.1
ncbi gb acc num :
NM_133492.2
ncbi pathways :
Metabolic Pathways (132956); Metabolism Pathway (477135); Metabolism Of Lipids And Lipoproteins Pathway (160976); Sphingolipid De Novo Biosynthesis Pathway (530750); Sphingolipid Metabolism Pathway (82994); Sphingolipid Metabolism Pathway (119543); Sphingolipid Metabolism Pathway (369); Sphingolipid Signaling Pathway (1144995); Sphingolipid Signaling Pathway (1158200); Sphingosine Biosynthesis Pathway (524497)
ncbi summary :
Ceramides are synthesized during epidermal differentiation and accumulate within the interstices of the stratum corneum, where they represent critical components of the epidermal permeability barrier. Excess cellular ceramide can trigger antimitogenic signals and induce apoptosis, and the ceramide metabolites sphingosine and sphingosine-1-phosphate (S1P) are important bioregulatory molecules. Ceramide hydrolysis in the nucleated cell layers regulates keratinocyte proliferation and apoptosis in response to external stress. Ceramide hydrolysis also occurs at the stratum corneum, releasing free sphingoid base that functions as an endogenous antimicrobial agent. ACER1 is highly expressed in epidermis and catalyzes the hydrolysis of very long chain ceramides to generate sphingosine (Houben et al., 2006 [PubMed 16477081]; Sun et al., 2008 [PubMed 17713573]).[supplied by OMIM, Jul 2010]
uniprot summary :
Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 8.0. Has a highly restricted substrate specificity for the natural stereoisomer of ceramide with D-erythro-sphingosine but not D-ribo-phytosphingosine or D-erythro-dihydrosphingosine as a backbone. May have a role in regulating the levels of bioactive lipids ceramide and sphingosine 1-phosphate, as well as complex sphingolipids ().